Last viewed:
ECOR
Prices are updated after-hours
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
(0.0% 1d)
(-11.7% 1m)
(-17.5% 1y)
(0.2% 2d)
(0.2% 3d)
(-0.4% 7d)
(29.01%
volume)
Earnings Calendar: 2024-03-06
Market Cap: $ 36,015,768
http://www.electrocore.com
Sec
Filling
|
Patents
| 51 employees
(United States) electroCore, Inc. is a commercial stage medical device company, which engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats, and Thomas J. Errico in September 2005 and is headquartered in Basking Ridge, NJ.
nervous system
add to watch list
Paper trade
email alert is off
Press-releases
Gastroparesis Market to Witness Upsurge in Growth at a CAGR of 7% by 2034 | DelveInsight
Published: 2024-04-10
(Crawled : 22:00)
- prnewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -3.09%
| O: -0.51%
H: 3.28%
C: 3.28%
growth
market
electroCore Announces the Launch of Truvaga Plus® for General Wellness
Published: 2024-04-08
(Crawled : 12:30)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -5.99%
| O: 0.83%
H: 0.0%
C: -3.47%
plus
wellness
for
electroCore Expands Intellectual Property Portfolio
Published: 2024-04-02
(Crawled : 12:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -7.68%
| O: -1.63%
H: 0.0%
C: -2.16%
electroCore Expands Intellectual Property PortfolioelectroCore Granted Two New U.S. Patents
Published: 2024-04-02
(Crawled : 23:00)
- biospace.com/
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -7.68%
| O: -1.63%
H: 0.0%
C: -2.16%
granted
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-13
(Crawled : 20:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -12.4%
| O: -3.72%
H: 4.67%
C: -1.93%
year
results
Electroceuticals Market / Bioelectric Medicine Market Worth $33.6 billion | MarketsandMarkets™
Published: 2024-03-13
(Crawled : 14:30)
- prnewswire.com
NVRO
|
$12.07
-2.03%
0.0%
390K
|
Health Technology
| -17.67%
| O: -0.55%
H: 1.99%
C: -1.65%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
| -7.3%
| O: 0.31%
H: 0.4%
C: -1.08%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
| -0.24%
| O: 0.16%
H: 0.0%
C: -2.31%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
| -10.73%
| O: 0.41%
H: 0.0%
C: 0.0%
STIM
|
$3.8
-0.78%
-0.79%
49K
|
Health Technology
| -11.83%
| O: -0.7%
H: 3.5%
C: -1.4%
LIVN
|
$52.31
-0.85%
-0.86%
430K
|
Health Technology
| 0.67%
| O: -0.6%
H: 2.36%
C: 1.18%
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -9.02%
| O: -0.16%
H: 4.03%
C: 4.03%
AXNX
|
$66.96
-0.13%
-0.13%
590K
|
Health Technology
| -1.03%
| O: 0.0%
H: 0.37%
C: 0.28%
market
electroCore to Participate in Upcoming Investor Conferences
Published: 2024-03-12
(Crawled : 12:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -14.52%
| O: -0.3%
H: 0.0%
C: -5.77%
electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024
Published: 2024-03-05
(Crawled : 21:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -14.78%
| O: 0.15%
H: 4.22%
C: 0.3%
year
financial
results
electroCore Expands Intellectual Property Portfolio
Published: 2024-02-06
(Crawled : 13:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -21.53%
| O: -1.04%
H: 3.41%
C: 1.82%
electroCore Expands Intellectual Property Portfolio
Published: 2024-01-09
(Crawled : 13:00)
- globenewswire.com
ECOR
|
$6.0
6.38%
6.0%
7.4K
|
Health Technology
| -3.09%
| O: 1.2%
H: 3.73%
C: 1.53%
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001193805-24-000057
4
2024-01-18
2024-01-16
Buy
A
75000
211060
0001193805-24-000050
4
2024-01-17
2024-01-12
Buy
P
16000
22437